Bret Weinstein on health: what the evidence says · JRE #2198

FACT CHECK // JRE #2198 // EXHIBIT LOG
EPISODE AIRED SEP 4, 2024 · THE JOE ROGAN EXPERIENCE
CLAIM CMTLWNLFSTATUS: PUBLISHED
SUBJECT: HEALTH
Timestamp1:31:20
Aired
// 00 · ABSTRACT

The short answer

Weinstein claims vaccine manufacturers received federal liability immunity under the Reagan administration because they said it was impossible to make vaccines safely. The National Childhood Vaccine Injury Act (NCVIA) was signed by President Reagan on November 14, 1986, creating the National Vaccine Injury Compensation Program (VICP) as a no-fault alternative to lawsuits and giving manufacturers liability protection conditioned on regulatory compliance.

RulingNeeds Context

Not a true/false call. Every claim is logged with its sources; read the exhibits below.

// THE CLAIM · ON TAPE
I believe it happened in the Reagan administration that they approached, they were reluctant to make vaccines. The Reagan administration wanted them to ratchet up production and they said, we can't, it can't be done safely.
Bret Weinstein@ 1:31:20
Watch on YouTubeJUMP TO 1:31:20

What the evidence says 01 / RECORD

The National Childhood Vaccine Injury Act (NCVIA) was signed by President Reagan on November 14, 1986, creating the National Vaccine Injury Compensation Program (VICP) as a no-fault alternative to lawsuits and giving manufacturers liability protection conditioned on regulatory compliance. The law followed a surge in DPT-related lawsuits in the early-to-mid 1980s (one filed in 1978 versus 73 in 1984), rising insurance and litigation costs, and manufacturers exiting the market; by 1984 only one company still made the DPT vaccine in the U.S. Historical accounts of the Act attribute manufacturers' reluctance to unpredictable multimillion-dollar jury verdicts, low profit margins, and unavailable liability insurance, not to a claim that vaccines could not be manufactured safely. No primary source reviewed shows manufacturers asserting production could not be done safely; the dispute was over legal and financial exposure from rare adverse events, not manufacturing feasibility. The claimed causal mechanism (a safety-impossibility assertion) misstates the documented liability/tort-reform rationale.

/// factcheckjoerogan.com